What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q2 2020?

185 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 88,614,685
Share change: -4,119,104
Total reported value: $1,334,393,703
Put/Call ratio: 169%
Price per share: $14.71
Number of holders: 185
Value change: -$51,210,796
Number of buys: 105
Number of sells: 86

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRANKLIN RESOURCES INC	13F	Company	7%	12,742,271	$149,588,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	4.4%	7,984,465	$93,738,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	3.3%	6,018,104	$70,653,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	3.1%	5,650,176	$66,334,000	—	31 Mar 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	2.4%	4,434,787	$52,064,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	1.9%	3,430,125	$40,270,000	—	31 Mar 2020	13F
Clearbridge Investments, LLC	13F	Company	1.9%	3,426,080	$40,222,000	—	31 Mar 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.7%	3,170,020	$37,216,000	—	31 Mar 2020	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	1.6%	2,896,904	$34,010,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	1.4%	2,577,742	$30,262,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	1.4%	2,519,602	$29,580,000	—	31 Mar 2020	13F
PFM Health Sciences, LP	13F	Company	1.4%	2,481,917	$29,138,000	—	31 Mar 2020	13F
FIL Ltd	13F	Company	1.4%	2,471,243	$29,013,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	1.3%	2,439,996	$28,647,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1.3%	2,325,103	$27,297,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.83%	1,508,906	$17,715,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.81%	1,485,527	$17,440,000	—	31 Mar 2020	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.77%	1,400,000	$16,436,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.38%	700,510	$16,092,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.66%	1,207,511	$14,176,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.62%	1,129,998	$13,266,000	—	31 Mar 2020	13F
Artisan Partners Limited Partnership	13F	Company	0.62%	1,129,917	$13,265,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.58%	1,051,892	$12,349,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.55%	1,006,642	$11,819,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.46%	837,534	$9,833,000	—	31 Mar 2020	13F
NEXPOINT ASSET MANAGEMENT, L.P.	13F	Company	0.43%	777,599	$9,129,000	—	31 Mar 2020	13F
C WorldWide Group Holding A/S	13F	Company	0.38%	702,069	$8,242,000	—	31 Mar 2020	13F
First Light Asset Management, LLC	13F	Company	0.38%	691,400	$8,117,000	—	31 Mar 2020	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	0.37%	670,238	$7,869,000	—	31 Mar 2020	13F
Pekin Hardy Strauss, Inc.	13F	Company	0.32%	588,732	$6,912,000	—	31 Mar 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.29%	537,420	$6,309,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.29%	521,181	$6,118,000	—	31 Mar 2020	13F
Elk Creek Partners, LLC	13F	Company	0.28%	509,174	$5,978,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.28%	507,854	$5,962,000	—	31 Mar 2020	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.27%	501,987	$5,893,000	—	31 Mar 2020	13F
Iron Triangle Partners LP	13F	Company	0.27%	500,000	$5,870,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.27%	498,460	$5,852,000	—	31 Mar 2020	13F
Sofinnova Investments, Inc.	13F	Company	0.26%	481,608	$5,654,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.23%	420,951	$4,942,000	—	31 Mar 2020	13F
OAK RIDGE INVESTMENTS LLC	13F	Company	0.21%	385,729	$4,528,000	—	31 Mar 2020	13F
HEARTLAND ADVISORS INC	13F	Company	0.21%	375,000	$4,403,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	361,653	$4,246,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.19%	355,554	$4,174,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	330,055	$3,875,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.16%	300,764	$3,531,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.16%	283,494	$3,329,000	—	31 Mar 2020	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.14%	262,344	$3,080,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.14%	260,630	$3,060,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.14%	260,235	$3,055,000	—	31 Mar 2020	13F
Squarepoint Ops LLC	13F	Company	0.12%	211,531	$2,483,000	—	31 Mar 2020	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2020

As of 30 Jun 2020, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 185 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 88,614,685 shares. The largest 10 holders included FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, STATE STREET CORP, Clearbridge Investments, LLC, WELLINGTON MANAGEMENT GROUP LLP, TANG CAPITAL MANAGEMENT LLC, and JPMORGAN CHASE & CO. This page lists 185 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

186

Q2 2020 holders

185

Holder diff

-1

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.